Expression changes in Fasl-deficient calvaria-derived osteoblasts: an RNA-seq analysis

Adela Kratochvilova1, Martina Zapletalova2, Reinhard Gruber3

  • 1Institute of Animal Physiology and Genetics, Czech Academy of Sciences, Brno, Czech Republic. adela.kratochvilova@iapg.cas.cz.

Scientific Data
|November 29, 2025
PubMed

Insights

The absence of FasL significantly alters gene expression in bone cells, impacting extracellular matrix and chemokine pathways. This study provides crucial transcriptomic data for understanding FasL

Area of Science:

  • Molecular Biology
  • Genomics
  • Bone Biology

Background:

  • FasL deficiency in mice (gld) is linked to bone abnormalities.
  • The molecular basis for FasL's role in bone biology is not fully understood.

Purpose of the Study:

  • To investigate the role of FasL in the gene expression profile of osteogenic cells.
  • To identify molecular mechanisms underlying bone phenotype alterations in FasL-deficient mice.

Main Methods:

  • RNA sequencing of primary calvaria-derived cells from wild-type and Fasl-deficient (gld) mice.
  • Analysis of gene expression profiles during osteogenic differentiation.
  • Enrichment analysis of differentially expressed genes.

Main Results:

  • The absence of FasL resulted in 480 upregulated and 301 downregulated genes.
  • Key affected pathways include extracellular matrix organization and chemokine signaling.
  • A publicly available transcriptomic dataset (GSE250608) was generated.

Conclusions:

  • FasL plays a significant role in regulating gene expression within osteogenic cells.
  • Transcriptomic changes associated with FasL deficiency provide insights into bone biology.
  • This dataset serves as a valuable resource for future research on FasL and bone health.